Schering’s new low-dose contraceptive approved in Netherlands
August 19, 2005Sales and Marketing
Yasminelle, a new low-dose oral contraceptive from Schering has received its first European marketing approval in the Netherlands. The country …
Recovery of healthcare PR highlights recruitment needs
August 18, 2005Medical Communications
The mood of optimism in healthcare PR is set to continue following an average 15% growth among agencies' net income …
Second batch of fake Lipitor discovered
August 18, 2005Manufacturing and Production
The MHRA has discovered a second batch of counterfeit Lipitor in under a month, a worrying indication of a growing …
Pfizer acquires antibody optimisation company
August 17, 2005Research and Development
Pfizer has purchased a company that develops technology to optimise antibodies to help it identify and develop new drugs with …
Acambis developing universal flu vaccine
August 17, 2005Research and Development
Acambis has started developing a flu vaccine that could alter the market by offering permanent protection against influenza and guarding …
Global giant VNU acquires IMS Health for $7 billion
August 17, 2005Sales and Marketing
Dutch media, consumer and marketing information group VNU has bought IMS Health for $7 billion, as it looks to expand …
FDA approves Diovan for cardiovascular indication
August 16, 2005Sales and Marketing
Novartis' biggest selling drug Diovan has received US approval for a new indication, as it strives to bolster its position …
Quintiles acquires site management organisation Profiad
August 11, 2005Research and Development
Contract research organisation Quintiles has acquired Profiad, a market-leading site management organisation, giving it access to the Reading-based firm clinical …
Increasing the appeal of science
August 10, 2005Research and Development
UK science students rate pharmaceutical companies as ideal employers, according to a new survey.GlaxoSmithKline, AstraZeneca and Pfizer are all rated …
New study says cancer risk from HRT only moderate
August 10, 2005Research and Development
The risk of developing breast cancer while on hormone replacement therapy may be lower than thought, according to a new …
Celebrex approved for new arthritis indication
August 8, 2005Sales and Marketing
Celebrex has received US approval for a new indication as Pfizer looks to revive tumbling sales of its flagship COX- …
DTC advertising to be tightened up
August 4, 2005Medical Communications
New US guidelines for pharmaceutical DTC advertising will come into effect next year as the industry seeks to address public …
Teva’s modest sales growth driven by MS treatment
August 4, 2005Sales and Marketing
Teva Pharmaceuticals, the world's number one generics manufacturer, has posted modest second quarter results driven by its patent-protected multiple sclerosis …
Animal rights attacks curbed by new legislation
August 4, 2005Animal rights activists have dramatically scaled back illegal attacks on medical researchers in the wake of new laws to counteract …
